Molecular monitoring of the diversity of human pathogenic malaria species in blood donations on Bioko Island, Equatorial Guinea.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
15 Jan 2019
Historique:
received: 06 09 2018
accepted: 08 01 2019
entrez: 17 1 2019
pubmed: 17 1 2019
medline: 12 2 2019
Statut: epublish

Résumé

Malaria can be transmitted by blood transfusion from human to human and it is responsible for the majority of transfusion-transmitted infectious diseases worldwide. In sub-Saharan Africa, it had been estimated that almost a quarter of blood donations contain malaria parasites. Since rapid diagnostic tests and thick blood smear microscopy lack sensitivity for low density parasitaemia, particularly in asymptomatic adults, the most reliable method to assess the problem of transfusion-transmitted malaria are nucleic acid-based molecular approaches such as quantitative polymerase chain reaction. The study was undertaken to determine the prevalence of sub-microscopic malaria parasite infection among blood donors in Malabo, Equatorial Guinea. Between July and August 2017, a total of 200 individual blood samples from blood donors at the Malabo Blood Bank were collected and screened by rapid diagnostic tests and thick blood smear microscopy. Retrospectively, the same samples were analysed for the presence of undetected, low-density malaria parasites using quantitative polymerase chain reaction. In comparison to 6.5% (13/200) by rapid diagnostic test and 2.0% (4/200) by microscopy, the proportion of Plasmodium falciparum positive blood donations analysed by quantitative polymerase chain reaction was significantly higher (26%, 52/200). Densities of P. falciparum positive blood donations were ranging from 0.06 to 3707.0 parasites/µL with 79.6% below 100 parasites/µL and therefore not detectable by non-molecular malaria diagnostic tests. qPCR based species identification revealed that P. falciparum was the dominating species responsible for 88.1% (52/59) of positive blood donations, followed by Plasmodium malariae (15.3%, 9/59) and Plasmodium ovale (3.4%, 2/59). This study confirms that in malaria endemic settings, sub-patent malaria infections among blood donors are prevalent. In blood collected from healthy donors living in Malabo, P. falciparum, P. malariae and P. ovale parasites were identified. Currently widely used malaria diagnostic tools have missed more than 75% of P. falciparum containing blood donations, demonstrating the value of quantitative polymerase chain reaction to reliably detect low density P. falciparum infections. Since the availability of molecular diagnostic methods in malaria endemic countries is still limited, the blood recipients living in malaria endemic countries should be treated following WHO recommendations.

Sections du résumé

BACKGROUND BACKGROUND
Malaria can be transmitted by blood transfusion from human to human and it is responsible for the majority of transfusion-transmitted infectious diseases worldwide. In sub-Saharan Africa, it had been estimated that almost a quarter of blood donations contain malaria parasites. Since rapid diagnostic tests and thick blood smear microscopy lack sensitivity for low density parasitaemia, particularly in asymptomatic adults, the most reliable method to assess the problem of transfusion-transmitted malaria are nucleic acid-based molecular approaches such as quantitative polymerase chain reaction. The study was undertaken to determine the prevalence of sub-microscopic malaria parasite infection among blood donors in Malabo, Equatorial Guinea.
METHODS METHODS
Between July and August 2017, a total of 200 individual blood samples from blood donors at the Malabo Blood Bank were collected and screened by rapid diagnostic tests and thick blood smear microscopy. Retrospectively, the same samples were analysed for the presence of undetected, low-density malaria parasites using quantitative polymerase chain reaction.
RESULTS RESULTS
In comparison to 6.5% (13/200) by rapid diagnostic test and 2.0% (4/200) by microscopy, the proportion of Plasmodium falciparum positive blood donations analysed by quantitative polymerase chain reaction was significantly higher (26%, 52/200). Densities of P. falciparum positive blood donations were ranging from 0.06 to 3707.0 parasites/µL with 79.6% below 100 parasites/µL and therefore not detectable by non-molecular malaria diagnostic tests. qPCR based species identification revealed that P. falciparum was the dominating species responsible for 88.1% (52/59) of positive blood donations, followed by Plasmodium malariae (15.3%, 9/59) and Plasmodium ovale (3.4%, 2/59).
CONCLUSIONS CONCLUSIONS
This study confirms that in malaria endemic settings, sub-patent malaria infections among blood donors are prevalent. In blood collected from healthy donors living in Malabo, P. falciparum, P. malariae and P. ovale parasites were identified. Currently widely used malaria diagnostic tools have missed more than 75% of P. falciparum containing blood donations, demonstrating the value of quantitative polymerase chain reaction to reliably detect low density P. falciparum infections. Since the availability of molecular diagnostic methods in malaria endemic countries is still limited, the blood recipients living in malaria endemic countries should be treated following WHO recommendations.

Identifiants

pubmed: 30646918
doi: 10.1186/s12936-019-2639-8
pii: 10.1186/s12936-019-2639-8
pmc: PMC6332537
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9

Subventions

Organisme : Equatorial Guinea Malaria Vaccine Initiative
ID : internal

Références

Am J Trop Med Hyg. 1999 Feb;60(2):183-7
pubmed: 10072133
Clin Microbiol Rev. 2002 Jan;15(1):66-78
pubmed: 11781267
J Clin Microbiol. 2005 May;43(5):2435-40
pubmed: 15872277
Clin Microbiol Rev. 2005 Jul;18(3):570-81
pubmed: 16020691
Int J Health Geogr. 2006 Jun 19;5:27
pubmed: 16784527
Clin Microbiol Rev. 2007 Oct;20(4):579-92
pubmed: 17934075
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):119-27
pubmed: 18165483
Clin Microbiol Infect. 2011 Jul;17(7):1101-7
pubmed: 20718798
Transfusion. 2011 Mar;51(3):630-5
pubmed: 20849405
Malar J. 2010 Nov 30;9:344
pubmed: 21114872
Rev Inst Med Trop Sao Paulo. 2011 Jan-Feb;53(1):55-9
pubmed: 21412621
Clin Infect Dis. 2011 May;52(9):1100-7
pubmed: 21467015
J Clin Microbiol. 2011 Aug;49(8):2946-53
pubmed: 21653767
PLoS Negl Trop Dis. 2011 Jun;5(6):e1192
pubmed: 21713024
Am J Trop Med Hyg. 2012 Mar;86(3):383-94
pubmed: 22403305
J Clin Microbiol. 2012 Dec;50(12):4012-9
pubmed: 23035191
Transfusion. 2013 Jul;53(7):1429-41
pubmed: 23113534
Clin Microbiol Infect. 2013 May;19(5):408-15
pubmed: 23373854
Clin Microbiol Infect. 2013 May;19(5):399-407
pubmed: 23438048
Clin Infect Dis. 2013 Jun;56(12):1735-41
pubmed: 23463635
J Infect Dis. 2013 Aug 15;208(4):645-52
pubmed: 23633405
J Clin Microbiol. 2013 Sep;51(9):2931-8
pubmed: 23804387
Transfus Apher Sci. 2013 Dec;49(3):416-21
pubmed: 23871466
PLoS One. 2013 Aug 29;8(8):e71539
pubmed: 24009663
J Med Microbiol. 2013 Oct;62(Pt 10):1491-505
pubmed: 24048274
J Clin Microbiol. 2014 Apr;52(4):1068-73
pubmed: 24430459
Malar J. 2014 Jul 28;13:288
pubmed: 25066459
Nat Rev Microbiol. 2014 Dec;12(12):833-40
pubmed: 25329408
Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):385-7
pubmed: 25453644
PLoS Negl Trop Dis. 2015 Jan 15;9(1):e0003469
pubmed: 25590587
PLoS Med. 2015 Mar 03;12(3):e1001788
pubmed: 25734259
Malar J. 2015 Dec 23;14:520
pubmed: 26701778
Transfus Med. 2016 Apr;26(2):153-5
pubmed: 27003788
Malar J. 2016 Apr 23;15:234
pubmed: 27108087
Lancet. 2016 Apr 23;387(10029):1753-61
pubmed: 27116282
Transfusion. 2016 Sep;56(9):2374-83
pubmed: 27339864
Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):15-34
pubmed: 27402513
Malar J. 2016 Jul 12;15(1):357
pubmed: 27405869
PLoS One. 2017 Apr 19;12(4):e0175771
pubmed: 28423028
BMC Public Health. 2017 May 18;17(1):470
pubmed: 28521798
Am J Trop Med Hyg. 2017 Nov;97(5):1540-1550
pubmed: 28820709
Am J Trop Med Hyg. 2018 Jan;98(1):308-318
pubmed: 29141739
Malar J. 2018 Jan 16;17(1):36
pubmed: 29338786
Lancet Infect Dis. 2018 May;18(5):565-572
pubmed: 29398388
Malar J. 2018 Feb 5;17(1):62
pubmed: 29402288
Lancet. 2018 Apr 21;391(10130):1608-1621
pubmed: 29631781
Am J Trop Med Hyg. 2018 Jul;99(1):17-23
pubmed: 29761762
Transpl Infect Dis. 2018 Oct;20(5):e12938
pubmed: 29863799

Auteurs

Tobias Schindler (T)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland. tobias.schindler@unibas.ch.
University of Basel, Basel, Switzerland. tobias.schindler@unibas.ch.

Tamy Robaina (T)

Malabo Blood Bank, Malabo, Equatorial Guinea.

Julian Sax (J)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Jose Raso Bieri (JR)

Equatorial Guinea Malaria Vaccine Initiative, Malabo, Equatorial Guinea.

Maximilian Mpina (M)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, United Republic of Tanzania.

Linda Gondwe (L)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, United Republic of Tanzania.

Ludmila Acuche (L)

Equatorial Guinea Malaria Vaccine Initiative, Malabo, Equatorial Guinea.

Guillermo Garcia (G)

Medical Care Development International, Silver Spring, USA.

Carlos Cortes (C)

Medical Care Development International, Silver Spring, USA.

Carl Maas (C)

Marathon EG Production Ltd, Malabo, Equatorial Guinea.

Claudia Daubenberger (C)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland. claudia.daubenberger@swisstph.ch.
University of Basel, Basel, Switzerland. claudia.daubenberger@swisstph.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH